FDA Adverse Event Injury Summary report: N

ENDURANT II STENT GRAFT

MDR report key: 12834742 · Received November 18, 2021

Report

Report Number
9612164-2021-04473
Event Type
Injury
Date Received
November 18, 2021
Date of Event
February 3, 2021
Report Date
November 18, 2021
Manufacturer
MEDTRONIC IRELAND
Product Code
MIH
PMA / PMN Number
P100021
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

MEDTRONIC RECEIVED THE FOLLOWING INFORMATION OBTAINED FROM THE JOURNAL ARTICLE ENTITLED; COMPARISON OF OUTCOMES FOLLOWING EVAR BASED ON ANEURYSM DIAMETER AND VOLUME AND THEIR POSTOPERATIVE VARIATIONS MONTELIONE ET AL, ANN VASC SURG VOLUME 74, P183-193, JULY 01, 2021 HTTPS://DOI.ORG/10.1016/J.AVSG.2020.12.048. EXACT DATE OF IMPLANT UNKNOWN. THE MORTALITY RATES WERE 7.2% HOWEVER THERE WAS NO INFORMATION TO SUGGEST ANY OF THE ENDURANT DEVICE FAILURES CAUSED OR CONTRIBUTED TO THE DEATHS. THERE WAS NO INFORMATION TO SUGGEST ANY ENDURANT DEVICE FAILURE CAUSED OR CONTRIBUTED TO A DEATH. DEATHS ARE COMMON OCCURRENCES HOWEVER THE CAUSE(S) OF DEATH ARE OFTEN NOT CHARACTERIZED OR CLEARLY ASSOCIATED WITH A PARTICULAR PRODUCT. THEREFORE, DEATHS WILL NOT BE CONSIDERED REPORTABLE AS MDR OR VIGILANCE UNLESS CLEARLY STATED AS BEING ASSOCIATED WITH MEDTRONIC PRODUCT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 0

ENDURANT AND ENDURANT II STENT GRAFT SYSTEMS WERE IMPLANTED FOR THE ENDOVASCULAR TREATMENT OF ABDOMINAL AORTIC ANEURYSMS ON UNKNOWN DATES. THE FOLLOWING ADVERSE EVENTS WERE REPORTED REINTERVENTION, FEMORAL PSEUDOANEURYSM, PARTIAL RENAL OCCLUSION, LIMBS OCCLUSION, RTBAD AND LIMB STENOSIS. THE CAUSE OF THE ADVERSE EVENTS ARE UNDETERMINED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1736609 ENDURANT II STENT GRAFT SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR MIH MEDTRONIC IRELAND UNK-CV-SR-ENDUR-II

Patients

Seq Age Sex Outcome Treatment
1 74 YR Male Required Intervention